Magic Green Oil Drops CBD

When it comes to the health benefits of CBD, it is often the case that the science says one thing and the marketing says another.

Take cancer. According to the National Cancer Institute (NCI), cannabinoids in the cannabis plant like non-high-inducing CBD may help treat the side effects of cancer. But clinical trials that study cannabis for cancer treatment are limited and there are no such ongoing studies in a vast database of more than 30 million citations maintained by the National Institutes of Health, NCI says.

You can’t rush the science. Yet many marketers of CBD products including, until recently, Magic Green Oil Drops, tout their CBD-infused capsules, oils and creams as a proven treatment for cancer, among other serious diseases. It seems it’s not until they are faced with the threat of legal action that they begin to tighten up their marketing.

In the case of Magic Green Oil Drops, that meant taking down its entire website in response to an FTC warning letter last month. The FTC had targeted claims on the website that the company’s CBD products, including its Complete Relief CBD supplements, are “clinically proven” to “[d]ecrease cancer spread,” “[c]ombat neurodegenerative disorders like Alzheimer’s” and improve symptoms of multiple sclerosis. The FTC also told the company:

It’s not enough that an endorsement represents the consumer’s honest opinion or experience. Reasonable consumers may interpret an endorsement claiming a health benefit from the use of a product as representing that the product is likely to be effective in achieving that benefit. Under FTC law, an advertiser must possess and rely on competent and reliable scientific evidence to support health claims, both express and implied, made through the use of endorsements.

The FTC also sent warning letters to the marketers of NuLife and Ocanna CBD products. TINA.org obtained the letters through a Freedom of Information Act request.

Read more about our coverage on CBD here.